ResMed | RMD - Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
Ansell USD 326.2M 27.6M 2024-06
Artivion USD 73.14M 1.25M 2025-12
AtriCure USD 109.31M 3.97M 2026-03
Baxter International USD 1.14B 251M 2026-06
Cochlear AUD 856.8M 430M 2025-12
Cooper Companies USD 735.4M 40.2M 2026-03
CSL USD 4.46B 2.71B 2025-12
Dexcom USD 750.3M 42.4M 2026-03
Edwards Lifesciences USD 1.35B 62.6M 2026-06
Fisher Paykel Healthcare NZD 784.4M 98.7M 2026-06
Globus Medical USD 548.17M 51.91M 2026-06
Haemonetics USD 202.8M 4.59M 2026-06
Idexx Laboratories USD 779.09M 56.35M 2026-06
Inogen USD 41.34M 1.39M 2024-09
Insulet USD 562.6M 21.8M 2026-06
Integra LifeSciences USD 215.97M 2.77M 2026-06
Intuitive Surgical USD 2.02B 193.4M 2026-06
Medtronic USD 6.01B 595M 2026-03
Philips EUR 2.15B 384M 2026-06
Ramsay Health Care AUD 549.95M 5.77B 2025-06
ResMed USD 861.22M 29.76M 2026-06
Sigma Healthcare AUD 160.13M 10.55M 2024-07
Sonic Healthcare AUD 3.92B 3.14B 2024-12
Steris USD 684.2M 12.9M 2026-06
Teleflex USD 331.71M 24.28M 2026-06
Thermo Fisher Scientific USD 4.49B 146M 2026-03